L, L., H, D., B, S., L, C., Y, Z., & Y, C. (2026). Dual-tracer PET/CT and cocktail therapy with [177Lu]Lu-FAP2286 and [177Lu]Lu-DOTATATE in G3 Neuroendocrine Tumors (NET). European journal of nuclear medicine and molecular imaging, 53(8), 4955. https://doi.org/10.1007/s00259-026-07833-2
Chicago Style (17th ed.) CitationL, Li, Ding H, Shen B, Chen L, Zhang Y, and Chen Y. "Dual-tracer PET/CT and Cocktail Therapy with [177Lu]Lu-FAP2286 and [177Lu]Lu-DOTATATE in G3 Neuroendocrine Tumors (NET)." European Journal of Nuclear Medicine and Molecular Imaging 53, no. 8 (2026): 4955. https://doi.org/10.1007/s00259-026-07833-2.
MLA (9th ed.) CitationL, Li, et al. "Dual-tracer PET/CT and Cocktail Therapy with [177Lu]Lu-FAP2286 and [177Lu]Lu-DOTATATE in G3 Neuroendocrine Tumors (NET)." European Journal of Nuclear Medicine and Molecular Imaging, vol. 53, no. 8, 2026, p. 4955, https://doi.org/10.1007/s00259-026-07833-2.